Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |